Home › X-Linked Bulbo-Spinal Atrophy › Utah
X-Linked Bulbo-Spinal Atrophy clinical trials in Utah
3 studies for X-Linked Bulbo-Spinal Atrophy are looking for participants at sites in Utah.
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT07190300A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Summit Urology, Murray
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07723248A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
- Research Site, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Aug 10, 2026 · NCT07336446From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.